Pharmaceutical Preparations · DE · CIK 886744
Develops and commercializes a telomerase inhibitor for blood cancers
Comparable business profile · signals at a glance
In the 90 days to Feb 18, 2026: 1 sold $19K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 18, 2026 | Robertson MichelleEVP, CHIEF FINANCIAL OFFICER | Sell | 9,855 | $1.94 | $19K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.